CHICAGO — Catheter ablation improved outcomes compared with antiarrhythmic drug therapy in patients with ventricular tachycardia and ischemic cardiomyopathy, researchers reported at the American Heart Association Scientific Sessions.“Patients who have ventricular tachycardia (VT) and shocks have worse outcomes than those who do not,” John L. Sapp, MD, FRCPC, FHRS, FCHRS,
Rigorous, dependable research has always been at the core of the American Heart Association (AHA) mission to be a relentless force for a world of…
In 1835, 189 years ago, a gathering of great chiefs of Aotearoa signed He Whakaputanga with representatives of the British Crown. Five years from that…
Non late-breaking abstracts are available as of Monday, November 6, 5:00 am ET/ 4:00 am CT. Late-breaking abstracts and presentations are embargoed until the day…
CHICAGO — Reconditioned cardiac devices could help meet an overwhelming need outside of the United States.In a new study presented at the American Heart Association…
Do electronic “nudges” or decision-support systems impact patient and clinician decision-making? Two separate studies presented at AHA 2024 explore answers to this question, specifically in…
BackgroundShort sleep duration has been associated with an increased risk of cognitive impairment and dementia. Short sleep is associated with elevated blood pressure, yet the…
AbstractBackgroundBeyond serving as a marker for insufficient physical activity, sedentary behavior may directly affect future cardiovascular (CV) disease risk.ObjectivesThis study sought to examin…
CHICAGO — Exenatide, an IV GLP-1 receptor agonist, did not improve clinical outcomes compared with placebo in patients undergoing heart surgery, according to the results…
WASHINGTON — Withholding Janus kinase or interleukin-17 inhibitors from patients with rheumatoid arthritis or spondyloarthritis does not significantly benefit COVID-19 booster response, according to data…
(UPDATED) Part 2 of this 7,000-patient trial suffered from discontinuations and low event rates: still, early MRAs did not impact CV events.
